Precision screening identifies mitoxantrone as a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison - Mohammed H. Al-Qahtani; Mourad Assidi; Abdelbaset Buhmeida; Asma Almuhammadi; Peter Natesan Pushparaj; Nofe Ateq Alganmi (PLoS ONE, 2026)